IN2013MU02581A - - Google Patents

Info

Publication number
IN2013MU02581A
IN2013MU02581A IN2581MU2013A IN2013MU02581A IN 2013MU02581 A IN2013MU02581 A IN 2013MU02581A IN 2581MU2013 A IN2581MU2013 A IN 2581MU2013A IN 2013MU02581 A IN2013MU02581 A IN 2013MU02581A
Authority
IN
India
Prior art keywords
tapentadol
salt
preparation
relates
present
Prior art date
Application number
Other languages
English (en)
Inventor
Kumar Yatendra
Swain Kapileswar
Suggala Vijay
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN2581MU2013 priority Critical patent/IN2013MU02581A/en
Publication of IN2013MU02581A publication Critical patent/IN2013MU02581A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN2581MU2013 2013-08-05 2013-08-05 IN2013MU02581A (enExample)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2581MU2013 IN2013MU02581A (enExample) 2013-08-05 2013-08-05

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2581MU2013 IN2013MU02581A (enExample) 2013-08-05 2013-08-05

Publications (1)

Publication Number Publication Date
IN2013MU02581A true IN2013MU02581A (enExample) 2015-06-12

Family

ID=54199325

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2581MU2013 IN2013MU02581A (enExample) 2013-08-05 2013-08-05

Country Status (1)

Country Link
IN (1) IN2013MU02581A (enExample)

Similar Documents

Publication Publication Date Title
EA201892395A1 (ru) Лекарственные составы ингибитора lsd1
ZA201606320B (en) Human plasma kallikrein inhibitors
MX2021011906A (es) Composiciones de liberacion retardada de linaclotida.
PH12015502002B1 (en) Tripeptide epoxy ketone protease inhibitors
IN2013MU03583A (enExample)
PH12015500587A1 (en) Combination of regorafenib and acetylsalicylic acid for treating cancer
MX2015010829A (es) Compuestos terapeuticos y sus usos.
JO3326B1 (ar) مثبطات إيبوكسي كيتون بروتياز ثلاثي الببتيد
HK1217092A1 (zh) 治疗性化合物及其用途
PH12016502352A1 (en) Pharmaceutical composition
TW201613578A (en) Pharmaceutical combinations
MX2021010297A (es) Inhibidores de calicreina plasmatica humana.
DOP2013000314A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
MX2015007488A (es) Composicion farmaceutica oftalmologica topica que contiene regorafenib.
MX2016004094A (es) Composicion farmaceutica que comprende capecitabina y ciclofosfamida.
GR1008228B (el) Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου
PH12020500045A1 (en) Novel composition of enzalutamide oral dosage form and method of manufacturing thereof
MX390369B (es) Inhibidores tripeptidicos de la epoxicetona proteasa
IN2013MU02582A (enExample)
IN2013MU02581A (enExample)
TW201613600A (en) Piperazinyl derivative reduces HFD-induced accumulation of fat in the liver, therapeutically
IN2013MU03428A (enExample)
MX2018013428A (es) Composicion farmaceutica de comprimido en comprimido que comprende ciclofosfamida y capecitabina.
UA81932U (ru) Комбинированный препарат "ротрин-дента" в виде геля для лечения воспалительных заболеваний слизистой оболочки полости рта
IN2013MU03639A (enExample)